Cadila Healthcare has entered into an agreement with Shilpa Medicare for the production of its COVID-19 vaccine, ZyCoV-D. The company has entered into a definitive agreement with Shilpa Medicare, via its wholly-owned subsidiary, Shilpa Biologicals for production-supply of the ZyCoV-D vaccine drug substance from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka.
The targeted production of the ZyCoV-D vaccine from this facility will be mutually agreed upon by both parties.
Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1523.80 |
Dr. Reddys Lab | 5959.10 |
Cipla | 1352.95 |
Zydus Lifesciences | 934.50 |
Lupin | 1599.65 |
View more.. |